ranitidine sandoz ranitidine 150mg (as hydrochloride) tablet blister pack
sandoz pty ltd - ranitidine hydrochloride -
ranitidine an ranitidine (as hydrochloride) 150mg tablet blister pack
amneal pharma australia pty ltd - ranitidine hydrochloride -
ranitidine tablet
contract pharmacy services-pa - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - ranitidine tablets are indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of rantidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acuter ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out
terry white chemists ranitidine ranitidine 300mg (as hydrochloride) tablet blister pack
apotex pty ltd - ranitidine hydrochloride -
terry white chemists ranitidine ranitidine 150mg (as hydrochloride) tablet blister pack
apotex pty ltd - ranitidine hydrochloride -
ranitidine-ga ranitidine (as hydrochloride) 300mg tablet blister pack
medis pharma pty ltd - ranitidine hydrochloride -
ranitidine-ga ranitidine (as hydrochloride) 150mg tablet blister pack
medis pharma pty ltd - ranitidine hydrochloride -
gabitidine- ranitidine hydrochloride, choline kit
physician therapeutics llc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - indications and usage ranitidine tablets, usp is indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulce
ranitidine- ranitidine hydrochloride tablet, film coated
wal-mart stores inc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - acid reducer - relieves heartburn associated with acid indigestion and sour stomach - prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
ranitidine- ranitidine hydrochloride tablet, film coated
wal-mart stores, inc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 75 mg - acid reducer